Quốc gia: Bỉ
Ngôn ngữ: Tiếng Anh
Nguồn: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Bordetella pertussis Filamentous Hemagglutinin (FHA) 8 µg/dose; Diphtheria Toxoid (DT) >= 2 IU/dose; Poliovirus Type 3 (inactivated) 32 D-antigen U/1 dose; Pertactin (Bordetella pertussis antigen) 2,5 µg/dose; Bordetella pertussis Toxoid (PT) 8 µg/dose; Tetanus Toxoid >= 20 IU/dose; Poliovirus Type 2 (inactivated) 8 D-antigen U/1 dose; Poliovirus Type 1 (inactivated) 40 D-antigen U/1 dose
GlaxoSmithKline Biologicals SA-NV
J07CA02
Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins
Suspension for injection
Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins
Intramuscular use
Diphtheria-Pertussis-Poliomyelitis-Tetanus
CTI code: 270426-02 - Pack size: 10 x 1 dose - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 270426-01 - Pack size: 1 dose - Commercialisation status: NO - Delivery mode: Medical prescription
Commercialised: No
2005-01-31